Exploration on the Interaction Ability of Antitumor Compound Bis-[2,6-difluoro-N-(hydroxyl-<κ>O)benzamidato-<κ>O]dibutylitin(IV) with Human Peroxisome Proliferator-Activated Receptor hPPARγ

Diorganotin(IV) antitumor compound bis-[2,6-difluoro-N-(hydroxyl-<κ>O)benzamidato-<κ>O] (DBDF2,6T) was one of the novel patent organotin compounds with high antitumor activity and relatively low toxicity. In this study, several methods were used to study the interaction between DBDF2,6T...

Descripción completa

Detalles Bibliográficos
Autores principales: Mai, Jiaqi, Li, Yunlan, Qiao, Xiaozhi, Ji, Xiaoqing, Li, Qingshan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015708/
https://www.ncbi.nlm.nih.gov/pubmed/29983705
http://dx.doi.org/10.1155/2018/3063271

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6015708/
https://www.ncbi.nlm.nih.gov/pubmed/29983705
http://dx.doi.org/10.1155/2018/3063271

Ejemplares similares